Ellsworth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.7M | Buy |
+101,492
| New | +$4.7M | 1.14% | 40 |
|
|
2023
Q3 | – | Sell |
-10,623
| Closed | -$679K | – | 168 |
|
|
2023
Q2 | $679K | Buy |
10,623
+482
| +5% | +$30.8K | 0.23% | 77 |
|
|
2023
Q1 | $703K | Buy |
10,141
+1,467
| +17% | +$102K | 0.25% | 70 |
|
|
2022
Q4 | $626K | Buy |
8,674
+1,754
| +25% | +$127K | 0.23% | 69 |
|
|
2022
Q3 | $492K | Buy |
6,920
+465
| +7% | +$33.1K | 0.21% | 73 |
|
|
2022
Q2 | $497K | Buy |
6,455
+3,316
| +106% | +$255K | 0.2% | 72 |
|
|
2022
Q1 | $243K | Buy |
+3,139
| New | +$243K | 0.09% | 127 |
|
|
2021
Q3 | – | Sell |
-3,357
| Closed | -$224K | – | 149 |
|
|
2021
Q2 | $224K | Sell |
3,357
-62
| -2% | -$4.14K | 0.11% | 138 |
|
|
2021
Q1 | $216K | Sell |
3,419
-199
| -6% | -$12.6K | 0.13% | 134 |
|
|
2020
Q4 | $224K | Buy |
3,618
+31
| +0.9% | +$1.92K | 0.16% | 108 |
|
|
2020
Q3 | $216K | Hold |
3,587
| – | – | 0.22% | 77 |
|
|
2020
Q2 | $211K | Buy |
+3,587
| New | +$211K | 0.23% | 70 |
|